The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...
The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...
The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...
Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.
It allows the agency to negotiate the price of drugs without generic or biosimilar competition that heavily cost Medicare Parts B and D. 2. The agency released the first round of negotiated prices ...
Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque psoriasis, psoriatic arthritis and oral ulcers by reducing inflammation in ...
Announcement of the 15 medicines chosen for the second round of negotiations was one of the Biden administration’s final ...
The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices that go into effect in 2027.
The plan also spent roughly $5.14 billion on Trelegy Ellipta, which was used by 1.3 million enrollees. Xtandi cost Medicare Part D $3.16 billion despite only 35,000 enrollees using the medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback